A double-blind, placebo-controlled trial of pioglitazone in the treatment of non-alcoholic steatohepatitis (NASH)

被引：0
|
作者：
Harrison, S
Belfort, R
Brown, K
Darland, C
Finch, J
Fincke, C
Havranek, R
Hardies, J
Dwivedi, S
Berria, R
Tio, FM
Schenker, S
Cusi, K
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A681 / A681
页数：1
相关论文
共 50 条
  • [31] Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
    Armstrong, Matthew James
    Gaunt, Piers
    Aithal, Guruprasad P.
    Barton, Darren
    Hull, Diana
    Parker, Richard
    Hazlehurst, Jonathan M.
    Guo, Kathy
    Abouda, George
    Aldersley, Mark A.
    Stocken, Deborah
    Gough, Stephen C.
    Tomlinson, Jeremy W.
    Brown, Rachel M.
    Huebscher, Stefan G.
    Newsome, Philip N.
    LANCET, 2016, 387 (10019): : 679 - 690
  • [32] Metadoxine Versus Placebo for the Treatment of Non-alcoholic Steatohepatitis: A Randomized Controlled Trial
    Shenoy, Kotacherry T.
    Balakumaran, Leena K.
    Mathew, Philip
    Prasad, Mohan
    Prabhakar, Boddu
    Sood, Ajit
    Singh, Shivaram P.
    Rao, Nagaraj P.
    Zargar, Shoukat A.
    Bignamini, Angelo A.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2014, 4 (02) : 94 - 100
  • [33] Role of pioglitazone (PIO) in patients with non-alcoholic steatohepatitis (NASH)
    Belfort, RS
    Harrison, S
    Brown, K
    Darland, C
    Finch, J
    Tio, F
    Gastaldelli, A
    Hardies, J
    Berria, R
    Dwivedi, S
    Havranek, R
    Balas, B
    Fincke, C
    DeFronzo, R
    Cusi, K
    DIABETOLOGIA, 2005, 48 : A280 - A280
  • [34] DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF NAPROXEN FOR THE TREATMENT OF DYSMENORRHEA
    DAWOOD, MY
    RIMANDORAMOS, J
    SPANN, J
    NILAND, N
    HALLADAY, S
    FRANCISCO, C
    SKARE, K
    BARTIZEK, R
    SORRENTINO, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 166 - 166
  • [35] A double-blind placebo-controlled trial of baclofen in the treatment of tinnitus
    Westerberg, BD
    Roberson, JB
    Stach, BA
    AMERICAN JOURNAL OF OTOLOGY, 1996, 17 (06): : 896 - 903
  • [36] A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia
    Vitton, O
    Gendreau, M
    Gendreau, J
    Kranzler, J
    Rao, SG
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2004, 19 : S27 - S35
  • [37] A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ACITRETIN FOR THE TREATMENT OF PSORIASIS
    OLSEN, EA
    WEED, WW
    MEYER, CJ
    COBO, LM
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 21 (04) : 681 - 686
  • [38] Interim analysis from a 72 week, double-blind, placebo-controlled, multicenter, paired liver biopsy study of endoscopic sleeve gastroplasty in patients with non-alcoholic steatohepatitis (NASH)
    Abad Guerra, Javier
    Arias Loste, Maria Teresa
    Burgos Santamaria, Diego
    Ampuero, Javier
    Martinez Porras, Jose Luis
    Iruzubieta, Paula
    Martin-Mateos, Rosa
    Ruiz Antoran, Belen
    Santos-Laso, Alvaro
    Graus, Javier
    Rincon, Adalberto
    Llop, Elba
    Romero Gomez, Manuel
    Albillos, Agustin
    Crespo, Javier
    Calleja Panero, Jose Luis
    JOURNAL OF HEPATOLOGY, 2021, 75 : S269 - S270
  • [39] The cult of the double-blind placebo-controlled trial
    Ellis, SJ
    Adams, RF
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1997, 51 (01): : 36 - 39
  • [40] Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial
    Kessoku, Takaomi
    Imajo, Kento
    Kobayashi, Takashi
    Ozaki, Anna
    Iwaki, Michihiro
    Honda, Yasushi
    Kato, Takayuki
    Ogawa, Yuji
    Tomeno, Wataru
    Kato, Shingo
    Higurashi, Takuma
    Yoneda, Masato
    Kirikoshi, Hiroyuki
    Kubota, Kazumi
    Taguri, Masataka
    Yamanaka, Takeharu
    Usuda, Haruki
    Wada, Koichiro
    Kobayashi, Noritoshi
    Saito, Satoru
    Nakajima, Atsushi
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (11): : 996 - 1007
12345